Prime Medicine Announces U.S. FDA Clearance of Investigational New Drug Application for PM577a in H1069Q-mutated Wilson Disease
Go back to Prime Medicine Announces U.S. FDA Clearance of Investigational New Drug Application for PM577a in H1069Q-mutated Wilson Disease| (NASDAQ: PRME) | Delayed: 3.08 +0.13 (4.41%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.95 | 52 Week High | $21.72 | |||
| Open | $3.00 | 52 Week Low | $18.36 | |||
| Day High | $3.12 | P/E | N/A | |||
| Day Low | $2.97 | EPS | $0.00 | |||
| Volume | 1,976,333 | |||||
